CETP expression protects female mice from obesity-induced decline in exercise capacity

PLoS ONE

Volumn 10, Issue 8, 2015, Pages

  Cappel, David A ^b   Lantier, Louise ^b   Palmisano, Brian T ^b   Wasserman, David H ^b   Stafford, John M ^a,b  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL ESTER TRANSFER PROTEIN; GLYCOGEN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA COACTIVATOR 1ALPHA; GLUTAMIC ACID; MALIC ACID; MALIC ACID DERIVATIVE;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CELL ISOLATION; CONTROLLED STUDY; DISEASE ASSOCIATION; EXERCISE; EXERCISE TOLERANCE; FAT MASS; FEMALE; GASTROCNEMIUS MUSCLE; GENE EXPRESSION REGULATION; GLYCOGEN ANALYSIS; LIPID DIET; MOUSE; MUSCLE MITOCHONDRION; NONHUMAN; OBESITY; OXYGEN CONSUMPTION; PROTEIN EXPRESSION; PROTEIN FUNCTION; RUN DISTANCE; TRANSGENIC MOUSE; UPREGULATION; WILD TYPE MOUSE; ADVERSE EFFECTS; ANIMAL; GENETICS; HUMAN; METABOLISM; OXIDATION REDUCTION REACTION; PATHOPHYSIOLOGY;

ANIMALS; CHOLESTEROL ESTER TRANSFER PROTEINS; DIET, HIGH-FAT; FEMALE; GENE EXPRESSION REGULATION; GLUTAMIC ACID; HUMANS; MALATES; MICE; MITOCHONDRIA, MUSCLE; OBESITY; OXIDATION-REDUCTION; PHYSICAL CONDITIONING, ANIMAL;

EID: 84943328969     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0136915     Document Type: Article

References (49)

1. Myers J, Prakash M, Froelicher V, Do D, Partington S, Atwood JE. Exercise capacity and mortality among men referred for exercise testing. The New England journal of medicine. 2002; 346(11):793-801. Epub 2002/03/15. doi: 10.1056/NEJMoa011858 PMID: 11893790.
2. Church TS, Cheng YJ, Earnest CP, Barlow CE, Gibbons LW, Priest EL, et al. Exercise capacity and body composition as predictors of mortality among men with diabetes. Diabetes care. 2004; 27(1):83-8. Epub 2003/12/25. PMID: 14693971.
3. James WP, Caterson ID, CoutinhoW, Finer N, Van Gaal LF, Maggioni AP, et al. Effect of sibutramine on cardiovascular outcomes in overweight and obese subjects. The New England journal of medicine. 2010; 363(10):905-17. doi: 10.1056/NEJMoa1003114 PMID: 20818901.
4. Rucker D, Padwal R, Li SK, Curioni C, Lau DC. Long term pharmacotherapy for obesity and overweight: updated meta-analysis. Bmj. 2007; 335(7631):1194-9. doi: 10.1136/bmj.39385.413113.25 PMID: 18006966; PubMed Central PMCID: PMC2128668.
5. Ribisl PM, Lang W, Jaramillo SA, Jakicic JM, Stewart KJ, Bahnson J, et al. Exercise capacity and cardiovascular/metabolic characteristics of overweight and obese individuals with type 2 diabetes: the Look AHEAD clinical trial. Diabetes care. 2007; 30(10):2679-84. Epub 2007/07/24. doi: 10.2337/dc06-2487 PMID: 17644623.
6. Kelley DE, Simoneau JA. Altered ratio of glycolytic to oxidative enzyme capacities of skeletal muscle in NIDDM. Diabetes. 1996; 45:371-. PMID: ISI:A1996UJ88300368.
7. Simoneau JA, Colberg SR, Thaete FL, Kelley DE. Skeletal muscle glycolytic and oxidative enzyme capacities are determinants of insulin sensitivity and muscle composition in obese women. FASEB journal: official publication of the Federation of American Societies for Experimental Biology. 1995; 9 (2):273-8. Epub 1995/02/01. PMID: 7781930.
8. Manson JE, Greenland P, LaCroix AZ, Stefanick ML, Mouton CP, Oberman A, et al. Walking compared with vigorous exercise for the prevention of cardiovascular events in women. The New England journal of medicine. 2002; 347(10):716-25. doi: 10.1056/NEJMoa021067 PMID: 12213942.
9. Sang H, Yao S, Zhang L, Li X, Yang N, Zhao J, et al. Walk-run training improves the anti-inflammation properties of high-density lipoprotein in patients with metabolic syndrome. The Journal of clinical endocrinology and metabolism. 2015; 100(3):870-9. doi: 10.1210/jc.2014-2979 PMID: 25514103.
10. Cappel DA, Palmisano BT, Emfinger CH, Martinez MN, McGuinness OP, Stafford JM. Cholesteryl ester transfer protein protects against insulin resistance in obese female mice. Molecular metabolism. 2013; 2(4):457-67. Epub 2013/12/12. doi: 10.1016/j.molmet.2013.08.007 PMID: 24327961; PubMed Central PMCID: PMC3854988.
11. Marotti KR, Castle CK, Boyle TP, Lin AH, Murray RW, Melchior GW. Severe atherosclerosis in transgenic mice expressing simian cholesteryl ester transfer protein. Nature. 1993; 364(6432):73-5. Epub 1993/07/01. doi: 10.1038/364073a0 PMID: 8316302.
12. Marotti KR, Castle CK, Murray RW, Rehberg EF, Polites HG, Melchior GW. The role of cholesteryl ester transfer protein in primate apolipoprotein A-I metabolism. Insights from studies with transgenic mice. Arterioscler Thromb. 1992; 12(6):736-44. Epub 1992/06/01. PMID: 1591233.
13. Barter PJ, Hopkins GJ, Calvert GD. Transfers and exchanges of esterified cholesterol between plasma lipoproteins. The Biochemical journal. 1982; 208(1):1-7. PMID: 6760853; PubMed Central PMCID: PMC1153921.
14. Villard EF, El Khoury P, Duchene E, Bonnefont-Rousselot D, Clement K, Bruckert E, et al. Elevated CETP Activity Improves Plasma Cholesterol Efflux Capacity From Human Macrophages in Women. Arterioscler Thromb Vasc Biol. 2012; 32(10):2341-9. Epub 2012/08/21. doi: 10.1161/ATVBAHA.112.252841 PMID: 22904275.
15. Asztalos BF, Swarbrick MM, Schaefer EJ, Dallal GE, Horvath KV, Ai M, et al. Effects of weight loss, induced by gastric bypass surgery, on HDL remodeling in obese women. J Lipid Res. 2010; 51 (8):2405-12. Epub 2010/07/16. doi: 10.1194/jlr.P900015 PMID: 20631298; PubMed Central PMCID: PMC2903819.
16. Fueger PT, Shearer J, Krueger TM, Posey KA, Bracy DP, Heikkinen S, et al. Hexokinase II protein content is a determinant of exercise endurance capacity in the mouse. The Journal of physiology. 2005; 566(Pt 2):533-41. Epub 2005/05/10.doi: 10.1113/jphysiol.2005.085043 PMID: 15878951; PubMed Central PMCID: PMC1464755.
17. Lantier L, Fentz J, Mounier R, Leclerc J, Treebak JT, Pehmoller C, et al. AMPK controls exercise endurance, mitochondrial oxidative capacity, and skeletal muscle integrity. FASEB journal: official publication of the Federation of American Societies for Experimental Biology. 2014. Epub 2014/03/22. doi: 10.1096/fj.14-250449 PMID: 24652947.
18. Mettauer B, Zoll J, Sanchez H, Lampert E, Ribera F, Veksler V, et al. Oxidative capacity of skeletal muscle in heart failure patients versus sedentary or active control subjects. Journal of the American College of Cardiology. 2001; 38(4):947-54. Epub 2001/10/05. PMID: 11583863.
19. Fujimoto Y, Donahue EP, Shiota M. Defect in glucokinase translocation in Zucker diabetic fatty rats. Am J Physiol Endocrinol Metab. 2004; 287(3):E414-23. PMID: 15138155.
20. Fujimoto Y, Torres TP, Donahue EP, Shiota M. Glucose toxicity is responsible for the development of impaired regulation of endogenous glucose production and hepatic glucokinase in Zucker diabetic fatty rats. Diabetes. 2006; 55(9):2479-90. Epub 2006/08/29. 55/9/2479 [pii] doi: 10.2337/db05-1511 PMID: 16936196.
21. Chan TM, Exton JH. A rapid method for the determination of glycogen content and radioactivity in small quantities of tissue or isolated hepatocytes. Anal Biochem. 1976; 71(1):96-105. Epub 1976/03/01. 0003-2697(76)90014-2 [pii]. PMID: 1275237.
22. Wu K, Cappel D, Martinez M, Stafford JM. Impaired-inactivation of FoxO1 contributes to glucose-mediated increases in serum very low-density lipoprotein. Endocrinology. 2010; 151(8):3566-76. Epub 2010/05/27. doi: 10.1210/en.2010-0204 PMID: 20501667; PubMed Central PMCID: PMC2940519.
23. Haseler LJ, Lin AP, Richardson RS. Skeletal muscle oxidative metabolism in sedentary humans: 31PMRS assessment of O2 supply and demand limitations. Journal of applied physiology. 2004; 97 (3):1077-81. doi: 10.1152/japplphysiol.01321.2003 PMID: 15133010.
24. Safdar A, Little JP, Stokl AJ, Hettinga BP, Akhtar M, Tarnopolsky MA. Exercise increases mitochondrial PGC-1alpha content and promotes nuclear-mitochondrial cross-talk to coordinate mitochondrial biogenesis. J Biol Chem. 2011; 286(12):10605-17. Epub 2011/01/20. doi: 10.1074/jbc.M110.211466 PMID: 21245132; PubMed Central PMCID: PMC3060512.
25. Wende AR, Huss JM, Schaeffer PJ, Giguere V, Kelly DP. PGC-1alpha coactivates PDK4 gene expression via the orphan nuclear receptor ERRalpha: a mechanism for transcriptional control of muscle glucose metabolism. Mol Cell Biol. 2005; 25(24):10684-94. Epub 2005/11/30. doi: 10.1128/MCB.25.24. 10684-10694.2005 PMID: 16314495; PubMed Central PMCID: PMC1316952.
26. Baar K, Wende AR, Jones TE, Marison M, Nolte LA, Chen M, et al. Adaptations of skeletal muscle to exercise: rapid increase in the transcriptional coactivator PGC-1. The FASEB journal: official publication of the Federation of American Societies for Experimental Biology. 2002; 16(14):1879-86. Epub 2002/12/07. doi: 10.1096/fj.02-0367com PMID: 12468452.
27. Wei M, Kampert JB, Barlow CE, Nichaman MZ, Gibbons LW, Paffenbarger RS Jr., et al. Relationship between low cardiorespiratory fitness and mortality in normal-weight, overweight, and obese men. Jama. 1999; 282(16):1547-53. PMID: 10546694.
28. Blair SN, Kohl HW 3rd, Barlow CE, Paffenbarger RS Jr., Gibbons LW, Macera CA. Changes in physical fitness and all-cause mortality. A prospective study of healthy and unhealthy men. Jama. 1995; 273 (14):1093-8. PMID: 7707596.
29. Neufer PD, Costill DL, Flynn MG, Kirwan JP, Mitchell JB, Houmard J. Improvements in exercise performance: effects of carbohydrate feedings and diet. Journal of applied physiology. 1987; 62(3):983-8. PMID: 3571097.
30. Coyle EF, Coggan AR, Hemmert MK, Ivy JL. Muscle glycogen utilization during prolonged strenuous exercise when fed carbohydrate. Journal of applied physiology. 1986; 61(1):165-72. PMID: 3525502.
31. Wright DA, Sherman WM, Dernbach AR. Carbohydrate feedings before, during, or in combination improve cycling endurance performance. Journal of applied physiology. 1991; 71(3):1082-8. PMID: 1757304.
32. Fueger PT, Bracy DP, Malabanan CM, Pencek RR, Granner DK, Wasserman DH. Hexokinase II overexpression improves exercise-stimulated but not insulin-stimulated muscle glucose uptake in high-fatfed C57BL/6J mice. Diabetes. 2004; 53(2):306-14. PMID: 14747279.
33. Hughes VA, Fiatarone MA, Fielding RA, Kahn BB, Ferrara CM, Shepherd P, et al. Exercise increases muscle GLUT-4 levels and insulin action in subjects with impaired glucose tolerance. Am J Physiol. 1993; 264(6 Pt 1):E855-62. PMID: 8333511.
34. St-Pierre J, Lin J, Krauss S, Tarr PT, Yang R, Newgard CB, et al. Bioenergetic analysis of peroxisome proliferator-activated receptor gamma coactivators 1alpha and 1beta (PGC-1alpha and PGC-1beta) in muscle cells. J Biol Chem. 2003; 278(29):26597-603. doi: 10.1074/jbc.M301850200 PMID: 12734177.
35. Bonnard C, Durand A, Peyrol S, Chanseaume E, Chauvin MA, Morio B, et al. Mitochondrial dysfunction results from oxidative stress in the skeletal muscle of diet-induced insulin-resistant mice. The Journal of clinical investigation. 2008; 118(2):789-800. doi: 10.1172/JCI32601 PMID: 18188455; PubMed Central PMCID: PMC2176186.
36. Tanigawa H, Billheimer JT, Tohyama J, Zhang Y, Rothblat G, Rader DJ. Expression of cholesteryl ester transfer protein in mice promotes macrophage reverse cholesterol transport. Circulation. 2007; 116(11):1267-73. Epub 2007/08/22. doi: 10.1161/CIRCULATIONAHA.107.704254 PMID: 17709636.
37. El Bouhassani M, Gilibert S, Moreau M, Saint-Charles F, Treguier M, Poti F, et al. Cholesteryl ester transfer protein expression partially attenuates the adverse effects of SR-BI receptor deficiency on cholesterol metabolism and atherosclerosis. J Biol Chem. 2011; 286(19):17227-38. Epub 2011/04/02. M111.220483 [pii] doi: 10.1074/jbc.M111.220483 PMID: 21454568; PubMed Central PMCID: PMC3089565.
38. Lehti M, Donelan E, Abplanalp W, Al-Massadi O, Habegger KM, Weber J, et al. High-density lipoprotein maintains skeletal muscle function by modulating cellular respiration in mice. Circulation. 2013; 128 (22):2364-71. Epub 2013/10/31. doi: 10.1161/CIRCULATIONAHA.113.001551 PMID: 24170386.
39. Tato F, Vega GL, Grundy SM. Bimodal Distribution of Cholesteryl Ester Transfer Protein Activities in Normotriglyceridemic Men With Low HDL Cholesterol Concentrations. Arteriosclerosis, Thrombosis, and Vascular Biology. 1995; 15(4):446-51. doi: 10.1161/01.atv.15.4.446 PMID: 7749855
40. de Vries R, Perton FG, Dallinga-Thie GM, van Roon AM, Wolffenbuttel BH, van Tol A, et al. Plasma cholesteryl ester transfer is a determinant of intima-media thickness in type 2 diabetic and nondiabetic subjects: role of CETP and triglycerides. Diabetes. 2005; 54(12):3554-9. Epub 2005/11/25. PMID: 16306375.
41. Arii K, Suehiro T, Yamamoto M, Ito H, Hashimoto K. Suppression of plasma cholesteryl ester transfer protein activity in acute hyperinsulinemia and effect of plasma nonesterified fatty acid. Metabolism. 1997; 46(10):1166-70. Epub 1997/10/10.S0026-0495(97)90211-0 [pii]. PMID: 9322801.
42. Berti JA, Casquero AC, Patricio PR, Bighetti EJB, Carneiro EM, Boschero AC, et al. Cholesteryl ester transfer protein expression is down-regulated in hyperinsulinemic transgenic mice. J Lipid Res. 2003; 44(10):1870-6. doi: 10.1194/jlr.M300036-JLR200 PMID: ISI:000186043900007.
43. Johansson LE, Danielsson AP, Parikh H, Klintenberg M, Norstrom F, Groop L, et al. Differential gene expression in adipose tissue from obese human subjects during weight loss and weight maintenance. Am J Clin Nutr. 2012; 96(1):196-207. Epub 2012/06/01. doi: 10.3945/ajcn.111.020578 PMID: 22648723.
44. Yoshino J, Conte C, Fontana L, Mittendorfer B, Imai S, Schechtman KB, et al. Resveratrol supplementation does not improve metabolic function in nonobese women with normal glucose tolerance. Cell Metab. 2012; 16(5):658-64. Epub 2012/10/30. doi: 10.1016/j.cmet.2012.09.015 PMID: 23102619; PubMed Central PMCID: PMC3496026.
45. Magkos F, Mohammed BS, Mittendorfer B. Plasma Lipid Transfer Enzymes in Non-Diabetic Lean and Obese Men and Women. Lipids. 2009; 44(5):459-64. doi: 10.1007/s11745-009-3285-7 PMID: ISI:000265770500008.
46. Arai T, Yamashita S, Hirano KI, Sakai N, Kotani K, Fujioka S, et al. Increased Plasma Cholesteryl Ester Transfer Protein in Obese Subjects. Arterioscler Thromb. 1994; 14(7):1129-36. PMID: WOS: A1994NW01300015.
47. MacLean PS, Vadlamudi S, MacDonald KG, Pories WJ, Barakat HA. Suppression of hepatic cholesteryl ester transfer protein expression in obese humans with the development of type 2 diabetes mellitus. Journal of Clinical Endocrinology & Metabolism. 2005; 90(4):2250-8. doi: 10.1210/jc.2004-1325 PMID: ISI:000228198900053.
48. Kahri J, Syvanne M, Taskinen MR. Plasma cholesteryl ester transfer protein activity in non-insulindependent diabetic patients with and without coronary artery disease. Metabolism. 1994; 43(12):1498-502. Epub 1994/12/01. PMID: 7990702.
49. MacLean PS, Bower JF, Vadlamudi S, Green T, Barakat HA. Lipoprotein subpopulation distributions in lean, obese, and type 2 diabetic women: a comparison of African and white Americans. Obes Res. 2000; 8(1):62-70. Epub 2000/03/11. doi: 10.1038/oby.2000.9 PMID: 10678260.